Good news about the small sale of ecobiotics holding in qbiotics. I do wonder if it is necessary to sell more after $2m raised, we wouldn't want our exposure to ebc-46 reduced more than necessary. $2m should give enough working capital for a while. If it needed to be done I would like to see it happen 6 or so months into Human phase I trials and offer the shares at $1 or more backed with some positive test results.
I heard the area around Yungaburra was damaged so lucky the blushwood trees were unscathed.
